Cemex S.A.B. De C.V. ADR (NYSE: CX) Seen Running Too Hot, Let’s Look At This More Closely

Currently, there are 1.51B common shares owned by the public and among those 1.51B shares have been available to trade.

The company’s stock has a 5-day price change of 5.59% and 14.96% over the past three months. CX shares are trading 17.03% year to date (YTD), with the 12-month market performance up to 68.59% higher. It has a 12-month low price of $5.16 and touched a high of $9.03 over the same period. CX has an average intraday trading volume of 6.50 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 9.65%, 12.09%, and 22.90% respectively.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Institutional ownership of Cemex S.A.B. De C.V. ADR (NYSE: CX) shares accounts for 29.01% of the company’s 1.51B shares outstanding.

It has a market capitalization of $13.71B and a beta (3y monthly) value of 1.47. The stock’s trailing 12-month PE ratio is 73.38, while the earnings-per-share (ttm) stands at $0.12. The company has a PEG of 5.40 and a Quick Ratio of 0.47 with the debt-to-equity ratio at 0.80. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.37% over the week and 2.48% over the month.

Analysts forecast that Cemex S.A.B. De C.V. ADR (CX) will achieve an EPS of $0.13 for the current quarter, $0.2 for the next quarter and $0.93 for 2025. The lowest estimate earnings-per-share for the quarter is $0.05 while analysts give the company a high EPS estimate of $0.22. Comparatively, EPS for the current quarter was $0.15 a year ago. Earnings per share for the fiscal year are expected to increase by 2480.75%, and 29.54% over the next financial year. EPS should grow at an annualized rate of 13.60% over the next five years, compared to -17.84% over the past 5-year period.

Looking at the support for the CX, a number of firms have released research notes about the stock. Barclays stated their Equal Weight rating for the stock in a research note on February 09, 2024, with the firm’s price target at $9. BofA Securities coverage for the Cemex S.A.B. De C.V. ADR (CX) stock in a research note released on January 09, 2024 offered a Buy rating with a price target of $9. Citigroup was of a view on November 02, 2023 that the stock is Buy, while BofA Securities gave the stock Neutral rating on May 15, 2023, issuing a price target of $6.80- $7.20. Citigroup on their part issued Neutral rating on May 05, 2023.

Most Popular

Related Posts